142 related articles for article (PubMed ID: 9013591)
1. Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin light chain.
Cornille F; Martin L; Lenoir C; Cussac D; Roques BP; Fournie-Zaluski MC
J Biol Chem; 1997 Feb; 272(6):3459-64. PubMed ID: 9013591
[TBL] [Abstract][Full Text] [Related]
2. A sensitive and rapid fluorescence-based assay for determination of tetanus toxin peptidase activity.
Soleilhac JM; Cornille F; Martin L; Lenoir C; Fournié-Zaluski MC; Roques BP
Anal Biochem; 1996 Oct; 241(1):120-7. PubMed ID: 8921173
[TBL] [Abstract][Full Text] [Related]
3. VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes.
Caccin P; Rossetto O; Rigoni M; Johnson E; Schiavo G; Montecucco C
FEBS Lett; 2003 May; 542(1-3):132-6. PubMed ID: 12729912
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.
Yamasaki S; Baumeister A; Binz T; Blasi J; Link E; Cornille F; Roques B; Fykse EM; Südhof TC; Jahn R
J Biol Chem; 1994 Apr; 269(17):12764-72. PubMed ID: 8175689
[TBL] [Abstract][Full Text] [Related]
5. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.
Schiavo G; Benfenati F; Poulain B; Rossetto O; Polverino de Laureto P; DasGupta BR; Montecucco C
Nature; 1992 Oct; 359(6398):832-5. PubMed ID: 1331807
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain.
Cornille F; Goudreau N; Ficheux D; Niemann H; Roques BP
Eur J Biochem; 1994 May; 222(1):173-81. PubMed ID: 8200342
[TBL] [Abstract][Full Text] [Related]
7. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
Sikorra S; Henke T; Galli T; Binz T
J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
[TBL] [Abstract][Full Text] [Related]
8. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
Shone CC; Roberts AK
Eur J Biochem; 1994 Oct; 225(1):263-70. PubMed ID: 7925446
[TBL] [Abstract][Full Text] [Related]
9. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
Foran P; Shone CC; Dolly JO
Biochemistry; 1994 Dec; 33(51):15365-74. PubMed ID: 7803399
[TBL] [Abstract][Full Text] [Related]
10. Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F.
Yamasaki S; Hu Y; Binz T; Kalkuhl A; Kurazono H; Tamura T; Jahn R; Kandel E; Niemann H
Proc Natl Acad Sci U S A; 1994 May; 91(11):4688-92. PubMed ID: 8197120
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin.
Schiavo G; Shone CC; Rossetto O; Alexander FC; Montecucco C
J Biol Chem; 1993 Jun; 268(16):11516-9. PubMed ID: 8505288
[TBL] [Abstract][Full Text] [Related]
12. Synaptobrevin cleavage by the tetanus toxin light chain is linked to the inhibition of exocytosis in chromaffin cells.
Höhne-Zell B; Ecker A; Weller U; Gratzl M
FEBS Lett; 1994 Nov; 355(2):131-4. PubMed ID: 7982485
[TBL] [Abstract][Full Text] [Related]
13. Active-site mutagenesis of tetanus neurotoxin implicates TYR-375 and GLU-271 in metalloproteolytic activity.
Rossetto O; Caccin P; Rigoni M; Tonello F; Bortoletto N; Stevens RC; Montecucco C
Toxicon; 2001 Aug; 39(8):1151-9. PubMed ID: 11306125
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates.
Perpetuo EA; Juliano L; Juliano MA; Fratelli F; Prado SM; Pimenta DC; Lebrun I
Protein Pept Lett; 2008; 15(10):1100-6. PubMed ID: 19075822
[TBL] [Abstract][Full Text] [Related]
15. An in vitro assay for detection of tetanus neurotoxin activity: using antibodies for recognizing the proteolytically generated cleavage product.
Kegel B; Behrensdorf-Nicol HA; Bonifas U; Silberbach K; Klimek J; Krämer B; Weisser K
Toxicol In Vitro; 2007 Dec; 21(8):1641-9. PubMed ID: 17826026
[TBL] [Abstract][Full Text] [Related]
16. How botulinum and tetanus neurotoxins block neurotransmitter release.
Humeau Y; Doussau F; Grant NJ; Poulain B
Biochimie; 2000 May; 82(5):427-46. PubMed ID: 10865130
[TBL] [Abstract][Full Text] [Related]
17. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
Cornille F; Roques BP
J Soc Biol; 1999; 193(6):509-16. PubMed ID: 10783709
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
19. Beta-amino-thiols inhibit the zinc metallopeptidase activity of tetanus toxin light chain.
Martin L; Cornille F; Coric P; Roques BP; Fournié-Zaluski MC
J Med Chem; 1998 Aug; 41(18):3450-60. PubMed ID: 9719598
[TBL] [Abstract][Full Text] [Related]
20. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
Chen S; Hall C; Barbieri JT
J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
